site stats

Ceptaris therapeutics inc

WebAug 1, 2013 · Stephen Tullman, President and CEO, Ceptaris Therapeutics, Inc. Related news: UPDATE 1-Actelion buys U.S.-based specialty drugmaker Ceptaris (Reuters) Reference links: Actelion press release. WebCeption Therapeutics Profile and History Ceptiontx.com is an information website that offers details on different biopharmaceutical products. Every drug that is a trailblazer in its particular category is analyzed and monitored for its therapeutic effects, the results of which are published on our website.

Ceptaris Therapeutics, Inc. Secures $10 Million in Series D-1 …

WebAug 27, 2013 · August 27, 2013. UPDATED August 29, 2013 — A new proprietary gel formulation of mechlorethamine ( Valchlor, Ceptaris Therapeutics Inc.) has been approved by the US Food and Drug Administration ... WebAug 26, 2013 · Ceptaris Therapeutics, Inc. is a privately held, specialty pharmaceutical company that has developed a proprietary gel formulation of mechlorethamine … blaq watches https://mergeentertainment.net

www.sec.gov

WebCompany: Ceptaris Therapeutics, Inc. Application No.: 202417 Approval Date: 8/23/2013. Persons with disabilities having problems accessing the PDF files below may call (301) … WebCeptaris Therapeutics (Formerly Yaupon Therapeutics) is developing potentially ground-breaking treatments for conditions such as drug addiction and cancer from compounds … WebJul 31, 2013 · VALCHLOR has a PDUFA date of 27 August 2013. Under the terms of the Merger Agreement, Actelion paid to Ceptaris USD 25 million upon signing and will pay to Ceptaris' shareholders USD 225 million ... franey refrigeration air conditioning inc

Ceptaris Therapeutics - Crunchbase Company Profile

Category:Manufacturers and Wholesalers Street City ST Zip - Nevada

Tags:Ceptaris therapeutics inc

Ceptaris therapeutics inc

Lisa Wittmer - Penn Center for Innovation

WebPrior to joining CorMedix, Mr. Lenz was Chief Financial Officer of Arno Therapeutics from July 2008 to February 2010, Chief Financial Officer of VioQuest Pharmaceuticals from April 2004 to June 2008, Controller of Chiral Quest, Inc., a subsidiary of VioQuest Pharmaceuticals, from October 2003 to March 2004, Controller of Smiths Detection from ... WebCeptaris Therapeutics, Inc is a corporation in Malvern, Pennsylvania. The employer identification number (EIN) for Ceptaris Therapeutics, Inc is 020555180. EIN for organizations is sometimes also referred to as taxpayer identification number or TIN or simply IRS Number. It is one of the corporates which submit 10-K filings with the SEC.

Ceptaris therapeutics inc

Did you know?

WebHe also served as Chairman, President and CEO of Ceptaris Therapeutics, Inc. until its acquisition by Actelion in 2013. He created Ception Therapeutics, Inc. in 2005 and served as its President and CEO until its acquisition by Cephalon, Inc. in 2010. Kelly Copeland Stephen Tullman WebTo report SUSPECTED ADVERSE REACTIONS, contact Ceptaris Therapeutics, Inc. at 1‐855‐4‐VALCHLOR (1‐855‐482‐5245) or FDA at 1‐800‐FDA‐1088 or …

WebFunding/Support: This study was supported in part by grant R01 FD003017 from the Office of Orphan Products Development of the Food and Drug Administration (Dr Lessin) and by Ceptaris Therapeutics, Inc. … WebCEPTARIS THERAPEUTICS, INC. IOWA FOREIGN PROFIT: WRITE REVIEW: Address: Lucas State Office Bldg 321 E. Walnut Des Moines, IA 50319: Registered Agent: Iowa Secretary Of State: Filing Date: April 06, 2012: File Number: 434638: View People Named Stephen Tullman in Pennsylvania: Contact Us About The Company Profile For Ceptaris …

WebCEPTARIS THERAPEUTICS, INC: Street Address 1 Street Address 2; 101 LINDENWOOD DRIVE: SUITE 400: City State/Province/Country ZIP/PostalCode Phone Number of … WebFeb 21, 2012 · Ceptaris Therapeutics, Inc. is a privately held, specialty pharmaceutical company that is developing a proprietary gel formulation of mechlorethamine …

WebManufactured for: Ceptaris Therapeutics, Inc., Malvern, PA 19355 © 2013 Ceptaris Therapeutics, Inc. All rights reserved. For more information, go to …

WebCEPTARIS THERAPEUTICS, INC. CALIFORNIA STOCK CORPORATION - OUT OF STATE - STOCK: WRITE REVIEW: Address: 5000 Shoreline Court Suite 200 South San Francisco, CA 94080: Registered Agent: C T Corporation System: Filing Date: February 24, 2014: File Number: 3648603: View People Named Bill Fairey in California franeys carpet one floor \\u0026 home visaliaWebMar 8, 2013 · Company: Ceptaris Therapeutics, Inc. Treatment for: Mycosis Fungoides. Valchlor (mechlorethamine) gel an alkylating agent indicated for the topical treatment of … bl arachnid\u0027sWebJul 31, 2013 · VALCHLOR has a PDUFA date of 27 August 2013. Under the terms of the Merger Agreement, Actelion paid to Ceptaris USD 25 million upon signing and will pay … blaque diamond wheels bd11WebCeptaris Therapeutics, Inc. produces and distributes pharmaceutical products. The Company offers prescription medications for the treatment of mycosis fungoides type of … blaqwirewrapsWebCeptaris Therapeutics General Information Description Developer of a proprietary gel formulation of mechlorethamine hydrochloride intended for the treatment of early-stage … franey surnameWebCompany Name Country [desc] Neurelis, Inc. USA: Archer Pharmaceuticals, Inc. USA: NeuroPhage Pharmaceuticals, Inc. USA: Argos Therapeutics, Inc. USA: Avanir ... blaq velvet clothingWebSep 20, 2013 · Actelion Ltd. ( ALIOF) completed the acquisition of privately-held Ceptaris Therapeutics. The acquisition closed on the heels of Ceptaris’ drug Valchlor gaining U.S. Food and Drug Administration ... blaque when the last teardrop falls